# How Atorvastatin Affects the Gut Flora and Metabolomics?

> **NCT04215237** · NA · UNKNOWN · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 30 (estimated)

## Conditions studied

- Atherosclerotic Cardiovascular Disease

## Interventions

- **DRUG:** Atorvastatin 20 Mg Oral Tablet

## Key facts

- **NCT ID:** NCT04215237
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-13
- **Primary completion:** 2020-06-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04215237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04215237, "How Atorvastatin Affects the Gut Flora and Metabolomics?". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04215237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*